A Wednesday night earnings report left big questions about how the spending reductions would affect the company.
2d
GlobalData on MSNFDA grants 510(k) clearance to Targeted Genomics’ GlutenID testThe US Food and Drug Administration (FDA) has granted 510(k) clearance to Targeted Genomics’ GlutenID test, designed to ...
Arima Genomics expands executive team with three strategic hires to advance clinical applications of 3D genomics.
Genomics (NASDAQ:TXG – Get Free Report) is projected to announce its earnings results after the market closes on Thursday, February 20th. Analysts expect 10x Genomics to post earnings of ($0.29) per ...
Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...
A major new investment into genomics research highlights the importance of genomics to New Zealand's future wellbeing and ...
Analysts at Leerink Partnrs decreased their Q1 2025 earnings estimates for shares of 10x Genomics in a research note issued to investors on Thursday, February 13th. Leerink Partnrs analyst P. Souda ...
SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common ...
12h
News Medical on MSNSurvey reveals public enthusiasm for personalizing medicine with genetic dataPharmacogenomics – an individual's genetic response to medications – is an increasingly important strand of personalised healthcare but little is known about the public's views on it.
International collaboration in genomic research is gaining momentum in African countries and is often supported by external ...
BGI Genomics' Indonesian joint venture NGI signed a partnership agreement for research collaboration with Indonesian ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results